|
Arteris, Inc.
Condensed Consolidated Balance Sheets (In thousands, except share and per share data) (Unaudited) | |||||||
| As of | |||||||
|
March 31,
2024 |
December 31,
2023 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 26,119 | $ | 13,696 | |||
| Short-term investments | 18,695 | 27,477 | |||||
| Accounts receivable, net of allowance of $93 as of both March 31, 2024 and December 31, 2023 | 12,265 | 12,003 | |||||
| Prepaid expenses and other current assets | 4,718 | 5,254 | |||||
| Total current assets | 61,797 | 58,430 | |||||
| Property and equipment, net | 5,244 | 5,745 | |||||
| Long-term investments | 8,602 | 11,802 | |||||
| Equity method investment | 7,741 | 8,500 | |||||
| Operating lease right-of-use assets | 4,060 | 4,289 | |||||
| Intangibles, net | 3,662 | 3,858 | |||||
| Goodwill | 4,178 | 4,178 | |||||
| Other assets | 6,070 | 5,999 | |||||
| TOTAL ASSETS | $ | 101,354 | $ | 102,801 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 754 | $ | 183 | |||
| Accrued expenses and other current liabilities | 12,659 | 11,831 | |||||
| Operating lease liabilities, current | 858 | 781 | |||||
| Deferred revenue, current | 33,558 | 31,537 | |||||
| Vendor financing arrangements, current | 1,987 | 2,070 | |||||
| Total current liabilities | 49,816 | 46,402 | |||||
| Deferred revenue, noncurrent | 26,559 | 25,172 | |||||
| Operating lease liabilities, noncurrent | 3,333 | 3,610 | |||||
| Vendor financing arrangements, noncurrent | 1,094 | 1,292 | |||||
| Deferred income, noncurrent | 8,520 | 8,810 | |||||
| Other liabilities | 2,486 | 2,412 | |||||
| Total liabilities | 91,808 | 87,698 | |||||
| Stockholders' equity: | |||||||
| Preferred stock, par value of $0.001 - 10,000,000 shares authorized as of both March 31, 2024 and December 31, 2023; no shares issued and outstanding as of both March 31, 2024 and December 31, 2023 | — | — | |||||
| Common stock, par value of $0.001 - 300,000,000 shares authorized as of both March 31, 2024 and December 31, 2023; 38,291,425 and 37,518,583 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 38 | 37 | |||||
| Additional paid-in capital | 122,104 | 118,193 | |||||
| Accumulated other comprehensive income | 54 | 120 | |||||
| Accumulated deficit | (112,650 | ) | (103,247 | ) | |||
| Total stockholders' equity | 9,546 | 15,103 | |||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 101,354 | $ | 102,801 | |||
